Shares of Proteome Sciences plc (LON:PRM – Get Free Report) fell 9.8% on Wednesday . The company traded as low as GBX 3.18 ($0.04) and last traded at GBX 3.18 ($0.04). 41,420 shares were traded during mid-day trading, a decline of 55% from the average session volume of 91,685 shares. The stock had previously closed at GBX 3.52 ($0.04).
Proteome Sciences Stock Performance
The stock has a market capitalization of £9.37 million, a PE ratio of -317.50 and a beta of 0.07. The firm’s 50 day moving average is GBX 2.90 and its two-hundred day moving average is GBX 3.12.
About Proteome Sciences
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.
Featured Articles
- Five stocks we like better than Proteome Sciences
- Using the MarketBeat Dividend Tax Calculator
- Moderna Shares Spike on H5N1 News—What’s Next for Investors?
- What is a SEC Filing?
- Nebius Group (NBIS): A Small-Cap Backed by NVIDIA
- Stock Sentiment Analysis: How it Works
- Natural Gas Demand to Surge: Top 3 Stocks and ETFs to Consider
Receive News & Ratings for Proteome Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proteome Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
